Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norihiro Watanabe

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal for Immunotherapy of Cancer|May 12, 2018
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activationPradip Bajgain, Supannikar Tawinwung, Lindsey D'Elia, et al.
Oncoimmunology|February 10, 2017
Fine-tuning the CAR spacer improves T-cell potencyNorihiro Watanabe, Pradip Bajgain, Sujita Sukumaran, et al.
Journal for Immunotherapy of Cancer|November 30, 2019
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevityAlejandro Torres Chavez, Mary Kathryn McKenna, Emanuele Canestrari, et al.
Leukemia Research|January 11, 2011
Generation of antigen-specific cytotoxic T lymphocytes using a leukemic plasmacytoid dendritic cell line as antigen presenting cellsAkie Yamahira, Miwako Narita, Takeshi Nakamura, et al.
Leukemia Research|March 27, 2010
Transformation of dendritic cells from plasmacytoid to myeloid in a leukemic plasmacytoid dendritic cell line (PMDC05)Norihiro Watanabe, Miwako Narita, Akie Yamahira, et al.
Acta Haematologica|October 25, 2008
Plasmacytoid dendritic cell leukemia with potent antigen-presenting abilityMiwako Narita, Takashi Kuroha, Norihiro Watanabe, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|November 28, 2007
Enhancement of anti-tumor cytotoxicity of expanded gammadelta T Cells by stimulation with monocyte-derived dendritic cellsAnri Saito, Miwako Narita, Ayumi Yokoyama, et al.
Medical Oncology (Northwood, London, England)|January 29, 2010
WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration intervalAnri Saitoh, Miwako Narita, Norihiro Watanabe, et al.
Leukemia Research|May 16, 2009
A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-alpha by stimulation via Toll-like receptors and present antigens to naïve T cellsMiwako Narita, Norihiro Watanabe, Akie Yamahira, et al.
Journal for Immunotherapy of Cancer|January 25, 2025
Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical studyThananya Inthanachai, Chatikorn Boonkrai, Tanapati Phakham, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|May 12, 2018
CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activationPradip Bajgain, Supannikar Tawinwung, Lindsey D'Elia, et al.
Oncoimmunology|February 10, 2017
Fine-tuning the CAR spacer improves T-cell potencyNorihiro Watanabe, Pradip Bajgain, Sujita Sukumaran, et al.
Journal for Immunotherapy of Cancer|November 30, 2019
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevityAlejandro Torres Chavez, Mary Kathryn McKenna, Emanuele Canestrari, et al.
Leukemia Research|January 11, 2011
Generation of antigen-specific cytotoxic T lymphocytes using a leukemic plasmacytoid dendritic cell line as antigen presenting cellsAkie Yamahira, Miwako Narita, Takeshi Nakamura, et al.
Leukemia Research|March 27, 2010
Transformation of dendritic cells from plasmacytoid to myeloid in a leukemic plasmacytoid dendritic cell line (PMDC05)Norihiro Watanabe, Miwako Narita, Akie Yamahira, et al.
Acta Haematologica|October 25, 2008
Plasmacytoid dendritic cell leukemia with potent antigen-presenting abilityMiwako Narita, Takashi Kuroha, Norihiro Watanabe, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|November 28, 2007
Enhancement of anti-tumor cytotoxicity of expanded gammadelta T Cells by stimulation with monocyte-derived dendritic cellsAnri Saito, Miwako Narita, Ayumi Yokoyama, et al.
Medical Oncology (Northwood, London, England)|January 29, 2010
WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration intervalAnri Saitoh, Miwako Narita, Norihiro Watanabe, et al.
Leukemia Research|May 16, 2009
A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-alpha by stimulation via Toll-like receptors and present antigens to naïve T cellsMiwako Narita, Norihiro Watanabe, Akie Yamahira, et al.
Journal for Immunotherapy of Cancer|January 25, 2025
Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical studyThananya Inthanachai, Chatikorn Boonkrai, Tanapati Phakham, et al.
Pageof 5